Expert Video - Why is it important to have diversity in lung cancer clinical trials?

Diversity in lung cancer clinical trials is explained by Manish Patel, DO, Associate Professor of Medicine at the University of Minnesota. Diversity in testing lung cancer treatments helps treatments for lung cancer be relevant to diverse racial, ethnic, social, and economic groups.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.

Patient Stories: